TM

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

The Dangers of Intrathecal Baclofen

By: Ada Seldin, Staff Editor - Intrathecal baclofen (ITB) is indicated for the treatment of intractable spasticity caused by spinal…

12 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

AUVI-Q™: The Newest Epinephrine Device to Hit the Market

By: Diana Gritsenko, Pharm D. Candidate c/o 2015 - Most of us who work in a community pharmacy setting will…

13 years ago

Ivacaftor (KalydecoTM): Targeting the Core of Cystic Fibrosis

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…

14 years ago

Duloxetine’s Effect on Blood Glucose Levels

By: Neal Shah, Co-Editor-in-Chief - Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US…

14 years ago

Naloxone Distribution Programs

By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article -…

14 years ago